| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22dac0df31985622b4c1a2ef109cc106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42db1215cfa4aa44233072d10f8b3eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b921adf1cc7b5c5e785fdd2bcbbb5ac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2162e05962315d425dd35da4225981fd |
| publicationDate |
2013-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2638898-A1 |
| titleOfInvention |
Metformin and Pioglitazone Formulation with Different Release Profiles |
| abstract |
The present invention relates to a bilayer tablet formulation providing a concomitant immediate release and controlled release. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111388438-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3342402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3025707-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109700777-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018122385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109700777-A |
| priorityDate |
2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |